(Q34394728)

1 August 2017

1 reference

title

Tuberculosis and HIV infection: epidemiology, immunology, and treatment (English)

1 reference

1 August 2017

1 reference

0 references

Schluger NW

1

1 reference

1 August 2017

Burzynski J

series ordinal

2

1 reference

1 August 2017

publication date

1 July 2001

1 reference

1 August 2017

1 reference

1 August 2017

volume

2

1 reference

1 August 2017

issue

4

1 reference

1 August 2017

page(s)

356-365

1 reference

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Accelerated course of human immunodeficiency virus infection after tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repeat

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Th1-Th2 paradigm: insights from leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Defining protective responses to pathogens: cytokine profiles in leprosy lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

The origin and erratic global spread of tuberculosis. How the past explains the present and is the key to the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. A risk to patients and health care workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections. Factors in transmission to staff and HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Pulmonary complications of HIV infection in Dar es Salaam, Tanzania. Role of bronchoscopy and bronchoalveolar lavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Radiographic presentation of pulmonary tuberculosis in severely immunosuppressed HIV-seropositive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Tuberculosis in HIV-positive patients: cellular response and immune activation in the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Preferential recruitment of phagocytes into the lung of patients with advanced acquired immunodeficiency syndrome and tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Incidence of tuberculosis in injection drug users in San Francisco: impact of anergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Control and prevention of tuberculosis in the United Kingdom: code of practice 2000. Joint Tuberculosis Committee of the British Thoracic Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

A tuberculin screening and isoniazid preventive therapy program in an inner-city population

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Adherence to tuberculosis preventive therapy among HIV-infected persons in Chiang Rai, Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American He

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Use of rifabutin with protease inhibitors for human immunodeficiency virus-infected patients with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Outcome of MDR-TB patients, 1983-1993. Prolonged survival with appropriate therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Undiagnosed tuberculosis in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Delayed diagnosis of tuberculosis in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

CD4 cell counts in human immunodeficiency virus-negative patients with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Risk factors for rifampin mono-resistant tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Risk factors for rifampin-monoresistant tuberculosis: A case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Eleven years of community-based directly observed therapy for tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clini

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Low antituberculosis drug concentrations in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Therapeutic implications of drug interactions in the treatment of human immunodeficiency virus-related tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Treatment of multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FTUNH-UAKU-N0E4-1PXF

10.1310/TUNH-UAKU-N0E4-1PXF

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference